Skip to main content
. 2019 Nov 19;28(1):3–13. doi: 10.1007/s12471-019-01342-8

Table 2.

Remote monitoring in heart failure (HF) patients using implantable cardioverter defibrillator/cardiac resynchronisation therapy (ICD/CRT) devices

Trial/study Author; journal; year No. of patients Parameter Endpoint Impact on HF hospitalisation
DOT-HF [16]

Van Veldhuisen et al.;

Circulation; 2011

 335 Intrathoracic impedance HF hospitalisation Increased
OptiLink [14]

Brachmann et al.;

Eur J Heart Fail; 2011

1002 Intrathoracic impedance HF hospitalisation Non-significant
EFFECT [17]

De Simone et al.;

Europace; 2015

 987 Remote monitoring via ICD, or CRT HF hospitalisation

Reduced

(IRR 0.54; 95% CI 0.24–0.62)

MORE-CARE [13]

Boriani et al.;

Eur J Heart Fail; 2017

 865 Remote monitoring of advanced diagnostics via CRT‑D HF hospitalisation Non-significant
REM-HF [15]

Morgan et al.;

Eur Heart J; 2017

1650 Remote monitoring via ICD, or CRT HF hospitalisation Non-significant
COMMIT-HF [18]

Kurek et al.;

J Cardiovasc Electrophysiol; 2017

 574 Remote monitoring via ICD, or CRT

HF hospitalisation/

All-cause mortality

Non-significant/

Reduced all-cause mortality (HR 0.24; 95% CI 0.14–0.41)

IN-TIME [19]

Hindricks et al;

Lancet; 2014

716 Remote monitoring via ICD, or CRT HF worsening score OR 0.63 95% Ci 0.43–0.90